Additionally, Lehn et al. 7 showed that the functional status of Rb appears to be related to the patient’s response to tamoxifen treatment and that the loss of RB function is associated with approximately 40% of ER-negative cancer as opposed to approximately 5% of ER-positive cases. Here, RB1 is linked to cancer.